Compare Medpace Holdings Inc (MEDP) vs Remitly Global Inc (RELY) Price & Performance

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

RELY trades at $24.25, up 4.8% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, with revenue of $495 million and adjusted EBITDA of $114.7 million, beating estimates. Revenue growth accelerated to 20% year-over-year, and net income turned positive in 2025, reaching $67.93 million. Recent initiatives include the launch of the Global Card and expansion in the UAE market.

The outlook is positive, driven by market share gains, new product launches, and improving profitability. Risks include competitive pressures in remittances and execution of growth initiatives. Analyst consensus is strongly bullish with a $31.00 price target, implying significant upside from current levels.